Bolenol

Clinical data
Other names	Ethylnorandrostenol; 17α-Ethyl-19-norandrost-5-en-17β-ol
Routes of administration	By mouth
Identifiers
IUPAC name (8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl-2,3,4,7,8,9,10,11,12,14,15, 16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
CAS Number	16915-78-9 Y
PubChem CID	11954311
ChemSpider	10128606 N
UNII	1BBD3123X6
ChEMBL	ChEMBL2104166 N
ECHA InfoCard	100.037.226
Chemical and physical data
Formula	C20H32O
Molar mass	288.475 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@H]3CCCC4)C)O
InChI InChI=1S/C20H32O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h8,15-18,21H,3-7,9-13H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1 N Key:VGXLQFPZGUQVQW-XGXHKTLJSA-N N
NY (what is this?)  (verify)

Bolenol (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name), also known as 17α-ethyl-19-norandrost-5-en-17β-ol (ethylnorandrostenol), is a synthetic, orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of 19-nortestosterone (nandrolone) that was never marketed.^[1] It was described in the literature in 1969.^[1]